Efficacy of Artemether-Lumefantrine and Amodiaquine-Artesunate for treatment of Uncomplicated Malaria in Children in Uganda

Trial Profile

Efficacy of Artemether-Lumefantrine and Amodiaquine-Artesunate for treatment of Uncomplicated Malaria in Children in Uganda

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Artemether/lumefantrine (Primary) ; Artesunate/amodiaquine (Primary)
  • Indications Malaria
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Dec 2015 New trial record
    • 23 Nov 2015 Status changed from not yet recruiting to completed, as published in the Journal of Infectious Diseases
    • 23 Nov 2015 Primary endpoint has been met. (Risk of treatment failure unadjusted and adjusted by genotyping at day 28), as published in the Journal of Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top